The mechanism of aqueous-phase asymmetric transfer hydrogenation (ATH) of acetophenone (acp) with HCOONa catalyzed by Ru-TsDPEN has been investigated by stoichiometric reactions, NMR probing, kinetic and isotope effect measurements, DFT modeling, and X-ray structure analysis. The chloride [RuCl(TsDPEN)(p-cymene)] (1), hydride [RuH(TsDPEN)(p-cymene)] (3), and the 16-electorn species [Ru(TsDPEN-H)(p-cymene)] (4) were shown to be involved in the aqueous ATH, with 1 being the precatalyst, and 3 as the active catalyst detectable by NMR in both stoichiometric and catalytic reactions. The formato complex [Ru(OCOH)(TsDPEN)(p-cymene)] (2) was not observed; its existence, however, was demonstrated by its reversible decarboxylation to form 3. Both 1 and 3 were protonated under acidic conditions, leading to ring opening of the TsDPEN ligand. 4 reacted with water, affording a hydroxyl species. In a homogeneous DMF/H(2)O solvent, the ATH was found to be first order in the concentration of catalyst and acp, and inhibited by CO(2). In conjunction with the NMR results, this suggests that hydrogen transfer to ketone is the rate-determining step. The addition of water stabilized the ruthenium catalyst and accelerated the ATH reaction; it does so by participating in the catalytic cycle. DFT calculations revealed that water hydrogen bonds to the ketone oxygen at the transition state of hydrogen transfer, lowering the energy barrier by about 4 kcal mol(-1). The calculations also suggested that the hydrogen transfer is more step-wise in nature rather than concerted. This is supported to some degree by the kinetic isotope effects, which were obscured by extensive H/D scrambling.
The sequence of reaction steps and the role of each reactant, required for the transformation of the Pd( 0] ϩ , 2a, the active Pd()-hydride catalyst for the methoxycarbonylation of ethene to methylpropanoate, have been delineated using a combination of spectroscopic and crystallographic methods. The preparation and characterisation of a variety of related complexes are described including some unusual examples involving bidentate sulfonate complexes and mono-cationic and neutral palladium hydride complexes. X-Ray crystal structures have been determined for [Pd(2-(CH 2 PCy 2 ) 2 C 6 H 4 ], 7, and [Pd(d t bpx)(η 2 -MeSO 3 )] ϩ , 9b.
A new protocol for the direct acylation of aryl bromides with aldehydes is established. It appears to involve palladium-amine cooperative catalysis, affording synthetically important alkyl aryl ketones in moderate to excellent yields in a straightforward manner, and broadening the scope of metal-catalyzed coupling reactions.
A detailed spectroscopic study has allowed the solution structure and dynamic properties
of all the intermediates in the Pd-catalyzed methoxycarbonylation of ethene to be established.
[Pd(L−L)H(solv)]+
1 (L−L = 1,2-(CH2PBut
2)2C6H4; solv = MeOH, 1a; PrnOH, 1b; THF, 1c;
EtCN, 1d) is static, and the two inequivalent P atoms do not become equivalent through
solvent exchange over all the temperatures studied.
2, contains a strong
β-agostic C−H interaction which is remarkably stable and is not displaced even in strongly
coordinating solvents such as EtCN. Cα and Cβ of the ethyl group in 2 become equivalent
via a stereospecific interchange involving [Pd(L−L)H(η
2-C2H4)]+ without making the two P
atoms equivalent; at higher temperatures these two inequivalent P atoms do become
equivalent probably via a T-shaped intermediate. For [Pd(L−L)(C(O)Et)(solv)]+, 6, there is
no
β-agostic C−H interaction and multiple 13C-labeling of the C(O)Et group shows that the
inequivalent P atoms become equivalent via movement of the intact C(O)Et group. The crystal
structure of the related complex [Pd(L−L)(C(O)Et)Cl] cocrystallized with dibenzylacetone
has been determined.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.